Navigation Links
Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
Date:3/29/2013

Ras Al Khaimah, UAE (PRWEB) March 29, 2013

Grace Century, FZ LLC, specializing in “game-changing” life science and health related private equity projects, recently announced the appointment of Yeow Fook (Eddie) Leong to their Advisory Board as Chief Compliance Officer. Leong brings decades of leadership, problem solving, and project leadership experience from Exxon Mobile.

Leong holds his Bachelors of Engineering from the University of Tokyo and is fluent in 5 languages. His international experience--which spans across 4 continents--along with his deep management background, has given him a keen vision of thinking “outside the box.”

Leong’s responsibilities with Grace Century will include due-diligence of potential new projects, ongoing oversight of accepted projects, and marketing coordination of existing projects in Asia and emerging markets. Like Grace Century, Leong will also take an equity participation in all projects, furthering his desire to bring all of Grace Century’s projects full-circle.

Grace Century President, Scott Wolf says, “I have yet to work with anyone who brings in the kind of energy, determination, and pragmatic stance that Eddie Leong brings to our process. He is truly an asset to Grace Century.”

Wolf further adds, “Eddie Leong realizes that all projects have benchmarks that must be met. When these benchmarks are met, they are then further analyzed to determine the areas that can be improved upon. And if these benchmarks are not met, an investigation and analytical review is conducted to determine why--so that alternative (better) steps can be quickly introduced. Simply put: Failure is never an option with Eddie Leong.”

###

About Grace Century
Grace Century, FZ LLC is an international research and private equity consulting company located in Ras Al Khaimah, United Arab Emirates (UAE). Grace Century specializes in conducting due-diligence for its group of international members, as well as assisting firms in the development and execution of “game changing” ideas in the life sciences and healthcare technology industries. Utilizing its vast network, Grace Century assists in capital formation, market penetration, joint ventures, and brand development.

Read the full story at http://www.prweb.com/releases/GraceCenturynews2013/03/prweb10572909.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
2. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
3. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
4. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
5. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
6. Agendia Signs Contract with Blue Shield of California
7. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
8. Volition Signs Collaboration Agreement With Abcodia
9. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
10. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017  Northwest Biotherapeutics (OTCQB: ... personalized immune therapies for solid tumor cancers, today ... million financing it announced last Friday, March 17, ... several institutional investors securities totaling 28,843,692 shares, comprised ... and 10,000,000 shares of Class C Warrants pre-funded ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... New Orleans, La. (PRWEB) , ... March 23, ... ... of real-time, industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” ... for APMT customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s ...
(Date:3/22/2017)... Good Start Genetics, a leading family genomics ... million covered lives mark through its most recent payor ... . With newly signed contracts nationally and others ... payor acceptance based on the quality of its science, ... its industry-leading customer care and support and its published ...
Breaking Biology Technology:
(Date:3/23/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market is ... next decade to reach approximately $14.21 billion by 2025. ... all the given segments on global as well as regional levels ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):